way 100135 has been researched along with ketanserin in 8 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (ketanserin) | Trials (ketanserin) | Recent Studies (post-2010) (ketanserin) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 3,094 | 335 | 283 |
| Protein | Taxonomy | way 100135 (IC50) | ketanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0016 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0021 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.265 | |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 6.5 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0184 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0027 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.29 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.8 | |
| Synaptic vesicular amine transporter | Homo sapiens (human) | 0.18 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fletcher, A; Marsden, CA; Mundey, MK | 1 |
| Friedman, E; Tilakaratne, N | 1 |
| Pestana, M; Soares-da-Silva, P; Vieira-Coelho, MA | 1 |
| Aguerre, S; Chaouloff, F; Mormede, P | 1 |
| Del Bel, EA; Guimarães, FS; Nucci-da-Silva, LP | 1 |
| Dunn, AJ; Swiergiel, AH | 1 |
| Höglund, AU; Kommalage, M | 1 |
| Abbasi-Maleki, S; Mesbahzadeh, B; Moradi-Kor, N | 1 |
8 other study(ies) available for way 100135 and ketanserin
| Article | Year |
|---|---|
Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Behavior, Animal; Carbidopa; Guinea Pigs; Ketanserin; Male; Neurons; Piperazines; Pyridines; Raphe Nuclei; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1996 |
Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Blotting, Northern; Brain; Cerebellum; Cerebral Cortex; Corpus Striatum; DNA Probes; Gene Expression; Gene Expression Regulation; Genes, fos; Genes, Immediate-Early; Hippocampus; Ketanserin; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; RNA, Messenger; Serotonin Antagonists; Serotonin Receptor Agonists | 1996 |
Antagonistic actions of renal dopamine and 5-hydroxytryptamine: endogenous 5-hydroxytryptamine, 5-HT1A receptors and antinatriuresis during high sodium intake.
Topics: Animals; Dihydroxyphenylalanine; Hemodynamics; Ketanserin; Kidney Tubules, Proximal; Male; Natriuresis; Piperazines; Potassium; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sodium; Time Factors | 1996 |
GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Hippocampus; Idazoxan; Ketanserin; Male; Mesencephalon; Mianserin; Nerve Endings; Oxadiazoles; Piperazines; Rats; Rats, Inbred WKY; Rats, Wistar; Reserpine; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Species Specificity; Tryptophan Hydroxylase | 1998 |
Serotonin modulation of catalepsy induced by N(G)-nitro-L-arginine in mice.
Topics: Adrenergic alpha-Antagonists; Animals; Bridged Bicyclo Compounds, Heterocyclic; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Indoles; Ketanserin; Male; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Piperazines; Prazosin; Ritanserin; Serotonin Antagonists; Time Factors | 1999 |
Lack of evidence for a role of serotonin in interleukin-1-induced hypophagia.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Eating; Interleukin-1; Ketanserin; Lipopolysaccharides; Male; Mice; Oxadiazoles; Piperazines; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Spiro Compounds; Sulfonamides | 2000 |
Involvement of spinal serotonin receptors in the regulation of intraspinal acetylcholine release.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Amphetamines; Animals; Biguanides; Citalopram; Dose-Response Relationship, Drug; Ketanserin; Male; Microdialysis; Piperazines; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Cord; Time Factors | 2005 |
Zinc enhances the expression of morphine-induced conditioned place preference through dopaminergic and serotonergic systems.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Ketanserin; Male; Morphine; Ondansetron; Piperazines; Rats; Rats, Wistar; Reward; Serotonin Antagonists; Sulpiride; Zinc | 2019 |